Telo Genomics (FRA:3D0A) Retained Earnings : €-18.51 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Telo Genomics Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Telo Genomics's retained earnings for the quarter that ended in Mar. 2024 was €-18.51 Mil.

Telo Genomics's quarterly retained earnings declined from Sep. 2023 (€-17.86 Mil) to Dec. 2023 (€-18.20 Mil) and declined from Dec. 2023 (€-18.20 Mil) to Mar. 2024 (€-18.51 Mil).

Telo Genomics's annual retained earnings declined from Jun. 2021 (€-13.71 Mil) to Jun. 2022 (€-16.47 Mil) and declined from Jun. 2022 (€-16.47 Mil) to Jun. 2023 (€-17.45 Mil).

Telo Genomics Retained Earnings Historical Data

The historical data trend for Telo Genomics's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Retained Earnings Chart

Telo Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Retained Earnings

Get a 7-Day Free Trial

-11.90

-12.53

-13.71

-16.47

-17.45

Telo Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Retained Earnings	Get a 7-Day Free Trial															-16.56	-17.45	-17.86	-18.20	-18.51

Telo Genomics Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Telo Genomics (FRA:3D0A) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Telo Genomics (FRA:3D0A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (FRA:3D0A) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

TDSGF:USA TELO:Canada

Address

101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7

Website

https://www.telodx.com

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (FRA:3D0A) Headlines

No Headlines